ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma

Scott C. Bresler, Daniel A. Weiser, Peter J. Huwe, Jin H. Park, Kateryna Krytska, Hannah Ryles, Marci Laudenslager, Eric F. Rappaport, Andrew C. Wood, Patrick W. McGrady, Michael D. Hogarty, Wendy B. London, Ravi Radhakrishnan, Mark A. Lemmon, Yaël P. Mossé

Research output: Contribution to journalArticlepeer-review

189 Scopus citations

Fingerprint Dive into the research topics of 'ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences